These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19363377)

  • 1. Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3-year follow-up.
    Glasner-Edwards S; Marinelli-Casey P; Hillhouse M; Ang A; Mooney LJ; Rawson R;
    J Nerv Ment Dis; 2009 Apr; 197(4):225-31. PubMed ID: 19363377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychopathology in methamphetamine-dependent adults 3 years after treatment.
    Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson RA;
    Drug Alcohol Rev; 2010 Jan; 29(1):12-20. PubMed ID: 20078677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiety disorders among methamphetamine dependent adults: association with post-treatment functioning.
    Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R;
    Am J Addict; 2010; 19(5):385-90. PubMed ID: 20716300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of depression outcomes among abstinent methamphetamine-dependent individuals exposed to an exercise intervention.
    Haglund M; Ang A; Mooney L; Gonzales R; Chudzynski J; Cooper CB; Dolezal BA; Gitlin M; Rawson RA
    Am J Addict; 2015 Apr; 24(3):246-251. PubMed ID: 25907813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life among treatment seeking methamphetamine-dependent individuals.
    Gonzales R; Ang A; Glik DC; Rawson RA; Lee S; Iguchi MY;
    Am J Addict; 2011; 20(4):366-72. PubMed ID: 21679268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical course and outcomes of methamphetamine-dependent adults with psychosis.
    Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R;
    J Subst Abuse Treat; 2008 Dec; 35(4):445-50. PubMed ID: 18294802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of treatment options for co-occurring methamphetamine use disorders and depression.
    Hellem TL; Lundberg KJ; Renshaw PF
    J Addict Nurs; 2015; 26(1):14-23; quiz E1. PubMed ID: 25761159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bulimia nervosa among methamphetamine dependent adults: association with outcomes three years after treatment.
    Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R
    Eat Disord; 2011; 19(3):259-69. PubMed ID: 21516550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Course of Methamphetamine-Induced Psychotic Disorder in a 3-Month Follow-Up.
    Javadian S; Shabani A; Shariat SV
    Prim Care Companion CNS Disord; 2016 Nov; 18(6):. PubMed ID: 27907276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attention-deficit/hyperactivity disorder among chronic methamphetamine users: frequency, persistence, and adverse effects on everyday functioning.
    Obermeit LC; Cattie JE; Bolden KA; Marquine MJ; Morgan EE; Franklin DR; Atkinson JH; Grant I; Woods SP;
    Addict Behav; 2013 Dec; 38(12):2874-8. PubMed ID: 24018233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying methamphetamine users at risk for major depressive disorder: findings from the methamphetamine treatment project at three-year follow-up.
    Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R;
    Am J Addict; 2008; 17(2):99-102. PubMed ID: 18393051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression and executive dysfunction contribute to a metamemory deficit among individuals with methamphetamine use disorders.
    Casaletto KB; Obermeit L; Morgan EE; Weber E; Franklin DR; Grant I; Woods SP;
    Addict Behav; 2015 Jan; 40():45-50. PubMed ID: 25222847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality, causes of death, and health status among methamphetamine users.
    Herbeck DM; Brecht ML; Lovinger K
    J Addict Dis; 2015; 34(1):88-100. PubMed ID: 25415384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profile of psychiatric symptoms in methamphetamine users in China: Greater risk of psychiatric symptoms with a longer duration of use.
    Ma J; Sun XJ; Wang RJ; Wang TY; Su MF; Liu MX; Li SX; Han Y; Meng SQ; Wu P; Shi J; Bao YP; Lu L
    Psychiatry Res; 2018 Apr; 262():184-192. PubMed ID: 29453037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in psychiatric symptoms among persons with methamphetamine dependence predicts changes in severity of drug problems but not frequency of use.
    Polcin DL; Korcha R; Bond J; Galloway G; Nayak M
    Subst Abus; 2016; 37(1):209-14. PubMed ID: 25775225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence.
    Heinzerling KG; Swanson AN; Kim S; Cederblom L; Moe A; Ling W; Shoptaw S
    Drug Alcohol Depend; 2010 Jun; 109(1-3):20-9. PubMed ID: 20092966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparisons of methamphetamine psychotic and schizophrenic symptoms: a differential item functioning analysis.
    Srisurapanont M; Arunpongpaisal S; Wada K; Marsden J; Ali R; Kongsakon R
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):959-64. PubMed ID: 21277930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between methamphetamine use, psychiatric comorbidities and treatment outcome in two inpatient rehabilitation centers.
    Lisa P; Felicia K; Laura H; Daniela K; Marlies R; Stefanie N; Maik SJ; Anne S; Maximilian S; Kirsi M; Michael S; Gabi K
    Psychiatry Res; 2019 Oct; 280():112505. PubMed ID: 31382181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creatine as a Novel Treatment for Depression in Females Using Methamphetamine: A Pilot Study.
    Hellem TL; Sung YH; Shi XF; Pett MA; Latendresse G; Morgan J; Huber RS; Kuykendall D; Lundberg KJ; Renshaw PF
    J Dual Diagn; 2015; 11(3-4):189-202. PubMed ID: 26457568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methamphetamine Use and Antipsychotic-related Extrapyramidal Side-effects in Patients with Psychotic Disorders.
    Temmingh HS; van den Brink W; Howells F; Sibeko G; Stein DJ
    J Dual Diagn; 2020; 16(2):208-217. PubMed ID: 31984872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.